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Introduction: Over the last years, electronic cigarettes (ECs) have become more popular, particularly in individuals
who want to give up smoking tobacco. The aim of the present study was to assess the influence of the different
e-smoking liquids on the viability and proliferation of human periodontal ligament fibroblasts.
Method and materials: For this study six test solutions with components from ECs were selected: lime-, hazelnut- and
menthol-flavored liquids, nicotine, propylene glycol, and PBS as control group. The fibroblasts were incubated up to 96 h
with the different liquids, and cell viability was measured by using the PrestoBlue® reagent, the ATP detection and the
migration assay. Fluorescence staining was carried out to visualize cell growth and morphology. Data were statistically
analyzed by two-tailed one-way ANOVA.
Results: The cell viability assay showed that the proliferation rates of the cells incubated with nicotine or the
various flavored liquids of the e-cigarettes were reduced in comparison to the controls, though not all reductions
were statistically significant. After an incubation of 96 h with the menthol-flavored liquid the fibroblasts were statistically
significant reduced (p < 0.001). Similar results were found for the detection of ATP in fibroblasts; the incubation with
menthol-flavored liquids (p < 0.001) led to a statistically significant reduction. The cell visualization tests confirmed these
findings.
Conclusion: Within its limits, the present in vitro study demonstrated that menthol additives of e-smoking have a
harmful effect on human periodontal ligament fibroblasts. This might indicate that menthol additives should be
avoided for e-cigarettes.
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The electronic nicotine-delivery device (electronic ciga-
rettes, ECs) was developed and patented in 2003 by the
Ruyan Group (Holdings) Limited in Beijing, China. After
their launch on the market in Europe and the United States
of America in 2006, e-cigarettes made headlines across the
world [1]. Praised as an alternative to conventional ciga-
rettes, e-cigarettes are intended for those who want to re-
duce or quit smoking. They can be used indoors when
restrictions on conventional smoking are present, and have
been marketed as environmentally friendly. The e-cigarette
is an electronic nicotine delivery device that mimics the
outward appearance of a conventional cigarette and has* Correspondence: willersh@uni-mainz.de
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article, unless otherwise stated.been recently introduced to the market worldwide [2].
While many different models are commercially avail-
able, all e-cigarettes consist of little more than three
basic components: a battery-part, a heating element
and a liquid-containing cartridge. The cartridge can be
filled with different e-liquid solutions. These liquids are
vaporized by the heating element, and the cigarette is
‘consumed’ by inhaling the liquids’ aerosol mist, thus
simulating the act of real tobacco smoking. The e-liquid is
a simple solution with usually three main components.
They contain diluents added to dilute the mixture and to
vaporize upon heating; the most commonly used diluents
are propylene glycol and vegetable or aqueous glycerin,
usually as a mixture of 80% propylene glycol and 20% gly-
cerin. In addition, flavors are often added to improve the
taste of the e-liquid. Nicotine is often added to the propyl-
ene glycol in concentrations up to 70 mg/ml. Propyleneentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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commonly used chemical without any known harmful ef-
fects on human health. Nicotine, in contrast, is considered
very harmful to both general and dental health. Tobacco
smoke induces changes in cell structure and function by
altering cell signaling pathways, which is predominantly
harmful to bronchial and oral epithelial cells [3-5]. Ad-
verse consequences on human health have been shown
even for low cigarette consumption [6]. Cigarette smoke
contains approximately 4800 chemicals, over 60 of which
are known to have adverse effects on human tissues and
cells, e.g. a high genotoxicity leading to various forms of
DNA damage [7]. Tobacco smoking is responsible for 85%
of lung carcinomas. According to WHO reports, cancer of
the oral cavity is the eleventh most common cancer
worldwide [8], while in South Central Asia it is the forth
most common cancer [9]. Besides being harmful to overall
health, the connection between smoking tobacco and
developing periodontal disease is well documented in
the literature. Studies have shown that smoking tobacco
contributes to the progression of periodontal disease
and adversely affects patients’ response to non-surgical
or surgical treatment [10-16]. Higher failure rates and
increased complications after dental implant placement
have also been documented in smokers [17]. Likewise,
smoking is a predisposing factor to acute necrotizing
ulcerative gingivitis [18]. Exposure to cigarette smoke is
also considered an independent periodontal disease risk
factor. Although e-cigarettes were initially introduced
as a healthy alternative to conventional smoking; however,
when they contain e-liquids supplemented with nicotine,
health risks associated with conventional tobacco con-
sumption might be expected. In a recent study it was
shown that 10 to 81% of the nicotine from the cartridges
was vaporized, corresponding to a range of 2.1 to 15.1 mg
nicotine [19]. According to a survey among users, e-
cigarettes are very popular, because they are supposed to
assist with smoking cessation [20]. In in-vitro studies it
has been shown that the vapors of the electronic ciga-
rettes were significantly less cytotoxic than cigarette
smoke extract [21].
The manufacturing process for e-liquids is not yet
standardized, which carries the risk that cancer-inducing
substances will enter the wide variety of e-liquids avail-
able on the market [22-25]. To date, tobacco-specific
substances such as nitrosamines and aldehydes have
already been detected in e-liquids. Since no evidence-
based studies on the effectiveness of e-cigarettes for
smoking cessation presently exist, and since the poten-
tially harmful health effects of e-cigarettes have also not
been tested, the use of e-cigarettes to replace cigarette
smoking can not be recommended.
The aim of the present in vitro study was to examine,
whether e-cigarette liquids and their various flavorcomponents have a damaging influence on the viability
and proliferation of human periodontal ligament fibroblast.
Material and methods
Cell culture
Clonetics® HPdLF (Human Periodontal Ligament Fibroblasts)
were purchased from Lonza (BioWhittaker, Kerviers,
Belgium). The fibroblasts were cultured in Dulbecco’s
Modified Eagle Medium (Molecular Probes, Carlsbad,
CA) containing 1% penicillin/streptomycin (Molecular
Probes, Carlsbad, CA) and 10% fetal bovine serum
(PAA, Pasching, Austria) and incubated under standard
cultivation conditions (37°C, 5% CO2 and 95% air).
Cells from the 4th to the 6th passage were used for the
PrestoBlue Viability Assay, the ApoGlow BioAssay, cell
visualization by means of fluorescence staining and the
Migration Assay.
Liquids for electronic cigarettes
The tested e-smoking liquids (eSmokerShop, GmbH,
Hannover, Germany) all contained in addition to various
flavors the components nicotine (20–22 mg/ml) and, as
additive, propylene glycol. Liquids with the flavors hazel-
nut (filbertone; trans-5-Methyl-2-hepten-4-one; 20 mg/ml
nicotine) [26], lime (20 mg/ml nicotine) [27,28] and
menthol (5-methyl-2-propan-2-ylcyclohexan-1-ol; 22 mg/ml
nicotine) as well as the test substances nicotine and
propylene glycol (Sigma-Aldrich Chemie GmbH, Steinsheim,
Germany) were included in the investigation. Dose–response
curves were established for nicotine and for the menthol-
flavored e-smoking liquid. From preliminary experiments
with the menthol-flavored liquid a concentration of
10 μg/ml was determined as best suited for all tests de-
scribed below. To allow for comparisons, all test liquids
were therefore diluted with serum-free Dulbecco’s
Modified Eagle Medium (DMEM), resulting in a final
nicotine concentration of 10 μg nicotine per ml test li-
quid. There were in total six test groups: control group
(PBS); propylene glycol; nicotine; three e-liquids, one
with hazelnut flavor, one with lime flavor and one with
menthol flavor. The following assays were employed to
study the influence of the above mentioned test solu-
tions on the vitality and proliferation of fibroblast cells.
PrestoBlue Cell Viability Assay
The PrestoBlue Cell proliferation assay (Molecular Probes,
Carlsbad, CA) contains a growth indicator which becomes
reduced by metabolically active cells to a fluorescent
agent. To investigate the influence of the different liquids,
the periodontal fibroblasts (10,000 cells/200 μl; n = 6 for
each test) were placed into 96 multi well plates and were
then incubated up to 96 h with the different liquids. Con-
trol cells were incubated only with the same volume of
DMEM.
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PrestoBlue, fluorescence was measured at a wavelength
of 530/25 nm and 590/35 nm with a fluorescence reader
(Synergy HT-Reader, BioTek, Winooski, VT). Logarithmic
signals were converted to a linear scale and expressed as
relative fluorescence units (RFU).
ATP-Detection
The ATP detection was performed with the ApoGlow
Bioassay kit (Lonza, BioWhittaker, Kerviers, Belgium).
For this assay 30,000 cells/well (n = 6 for each test) were
grown to confluence for about 24 h. The supernatants
were removed and the cells were incubated for 24 h with
the various test liquids. Then ATP was determined using
the ApoGlow Bioassay kit. Luminescence was mea-
sured with a luminescence reader (Synergy HT-Reader,
BioTek, Winooski, VT) and analyzed with Gen 5 (BioTek,
Winooski, VT).
Cell visualization
Calcein-AM/ethidium homodimer II staining (LIVE/DEAD
Viability/Cytotoxicity Kit; Molecular Probes, Carlsbad, CA)
is a two-color fluorescence-based method for determining
viability of cultured cells. Calcein is a fluorogenic esterase
substrate that is hydrolyzed intracellularly to a green fluor-
escent product, which is an indicator of live cells. Ethidium
homodimer enters cells with damaged membranes and in-
tercalates with the DNA in the nucleus, emitting a red
fluorescent signal. For cell visualization, the fibroblasts were
incubated for 24 h with the different test solutions and after
removal of the supernatant incubated with calcein-AM
(5 μl/10 ml)/ethidium homodimer II (10 μl/10 ml) at
37°C for 15 min. The stained cells were then viewed in
an inverted microscope at wave lengths of 450/520 nm
(Axiovert 40C, Carl Zeiss, Jena, Germany) at a magnifi-
cation of ×100.
Migration assay
The migration assay (Greiner Bio-One GmbH, Frickenhausen,
Germany) was performed with Boyden-Chambers (ThinCerts,
Greiner Bio-One GmbH, Frickenhausen, Germany). For
this investigation the fibroblasts (10,000 cells/well; n = 6
for each test) were placed in Boyden-Chambers. The two
compartments of the Boyden-Chamber are separated by a
porous PET membrane. Then the test liquids (600 μl with a
final concentration of 10 μg/ml nicotine) were added and
incubated for 72 h at standard culture conditions. Migra-
tory cells move through the pores. The fibroblasts were
stained with calcein-AM (5 μl and 10 ml PBS) for 15 min
under culture condition. After incubation the cells were
rinsed, placed in a new 24 multi-well chamber, and then in-
cubated for 30 min with 300 μl trypsin/EDTA. Afterwards,
aliquots of 200 μl were placed in a black 96 multi-well plate.
Fluorescence was measured at a wavelength of 485/20 nmand 520/40 nm with a fluorescence reader (Synergy HT-
Reader, BioTek, Winooski, VT) and analyzed with Gen 5
(BioTek, Winooski, VT). Logarithmic signals were con-
verted to a linear scale and expressed as relative fluores-
cence units (RFU).
Statistical analysis
The statistical analyses of the data were performed using
SPSS 20.0 (SPSS Inc., Chicago, Il.). For descriptive ana-
lyses, means and standard deviations were calculated for
the normally distributed continuous outcome variables.
For confirmatory analyses two-tailed one-way ANOVA
were performed to calculate overall p-values for the
comparison of the different groups for each outcome
variable.
Normality for outcomes was checked by visual inspec-
tion via quantile-quantile plots.
A power analysis for an ANOVA design was per-
formed. With a sample size of n = 6 per group a power
between 75% and 100% is available for 7 outcomes.
The global significance level for all statistical test pro-
cedures was chosen as α = 0.05.
Post-hoc tests employing the Bonferroni correction for
multiple testing were used for comparison of means of
two groups.
Results
As can be seen in Figure 1, the PrestoBlue Cell viability
assay showed that over an incubation time of 96 h the
proliferation rates of the cells incubated with nicotine or
the various flavored liquids of the e-cigarettes were re-
duced in comparison to that of the untreated control cells,
though not all reductions were statistically significant.
Starting at 24 h, the highest reduction in the proliferation
was observed for the treatment with menthol-flavored liq-
uids, which was the only statistically significant reduction
as compared to control cells.
After an incubation time of 48 h with the menthol-
flavored liquid the difference in comparison both to the
control cells and the nicotine-treated cells was highly
statistically significant (p < 0.001). Hazelnut flavor or
lime flavor only caused a slight not statistically signifi-
cant reduction of the proliferation rates at 48 h. After
96 h of incubation this strong growth-reducing effect of
the menthol-flavored liquids persisted and was still sta-
tistically significant.
More pronounced differences were found using the
ApoGlow Bioassay kit for the detection of ATP in fibro-
blasts after an incubation time of 24 h with the different
test substances and flavored liquids (Figure 2). In compari-
son to the untreated cells, incubation with hazelnut-flavored
(p < 0.024), lime-flavored (p < 0.009) or menthol-flavored
liquids (p < 0.001) led to a statistically significant reduction














Control Propylene glycol Nicotine Lime flavor Hazelnut flavor Menthol flavor
Figure 1 Effect of the different components and flavors of e-cigarettes up to 96 h, as assessed by PrestoBlue Cell viability assay. *p < 0.001
for cells incubated with menthol-flavored liquids versus controls for 24 h and for cells incubated with menthol-flavored liquids versus controls
and nicotine-treated cells 48-96 h.
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firmed by the visual analysis of the cells stained with
calcein-AM/ethidium homodimer II. The untreated hu-
man periodontal ligament fibroblasts and those incubated
for 24 h with propylene glycol showed good proliferation
(Figures 3A,B). Those incubated with nicotine, hazelnut-
or lime-flavored liquids showed a slight (Figures 3C-E)








Control Propylene glycol Nicotine
R
LU
Figure 2 ATP detection in the fibroblasts at an incubation time of 24
incubated with hazelnut-flavored liquids versus controls; p < 0.009 for cells
incubated with menthol-flavored liquids versus controls.flavored liquid produced a strong growth inhibition
(Figures 3F).
The inhibitory effect of menthol flavor exposure on the
fibroblast cells was especially noticeable in the migration
assay (Figure 4). Only the menthol-flavored liquid caused
a highly statistically significant reduction (p < 0.001) of cell
migration after 72 h in comparison to the control cells as
well as to the cells treated with nicotine.Hazelnut flavor Lime flavor Menthol flavor
h with the cigarette components and flavors. *p < 0.024 for cells
incubated with lime-flavored liquids versus controls; p < 0.001 for cells
Figure 3 Reaction of the fibroblasts stained with calcein-AM/ethidium homodimer II. Reaction of the periodontal ligament fibroblasts to
the different liquids (A = control; B = propylene glycol; C = nicotine; D = hazelnut flavor, E = lime flavor, F = menthol flavor), stained with
calcein-AM/ethidium homodimer II after an incubation time of 24 h (magnification ×100, bar = 100 μm).
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In the present study a possible harmful influence of
components and different available flavors of e-cigarettes
on human fibroblast cells was examined. E-cigarettes
have received a great deal of attention and popularity
over the past years and they also play an important role
in nicotine replacement therapy [29]. E-cigarettes
present a valuable alternative for smokers who are
willing to quit. Therefore, it is of interest to what ex-
tent the main components of the electronic cigarette
smoking liquids are potentially harmful. A novelty in
e- cigarettes is flavoring as additive and the liquids come








Control Propylene glycol Nicotine
R
FU
Figure 4 Effect of the different components and flavors of e-cigarette
controls and nicotine-treated cells.In our in vitro study it was demonstrated that some ad-
ditives from e-cigarettes could cause considerable damage
to cell proliferation. While some flavorings such as lime or
hazelnut did not seem to exert a harmful effect on cell vi-
tality and proliferation, the menthol e-liquid preparation
had significant negative impact on periodontal ligament
fibroblasts.
In their in vitro study Semlali et al. [30] explored the in-
fluence of whole cigarette smoke on the morphology and
function of gingival fiboblasts. The authors were able to
prove reduced cellular proliferation and vitality, further
a reduction of the number of β1-integrin-positive cells
together with an increased LDH activity [26]. TheseHazelnut flavor Lime flavor Menthol flavor
s on the migration rate of fibroblasts at 72 h. *p < 0.001 versus
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smoke can produce morphological and functional deregu-
lation in gingival fibroblasts.
The effect of numerous refill solutions of e-cigarettes
from an American distributor on human embryonic stem
cells and human pulmonary fibroblasts were tested, and it
was also shown that various additives such as cinnamon
or menthol had a cytotoxic potential [31].
It is known that in particular menthol as a tobacco
additive has the effect of masking the bitter taste of
cigarette smoke; it was first introduced into cigarettes in
1926 [32].
Conventional and electronic cigarettes often contain
menthol. Various effects have been suggested for men-
thol, such as taste ameliorating, cooling, pain-relieving
and a slightly numbing effect; menthol ameliorates the
cigarette taste, masks the irritating effect of tobacco
smoke and makes the smoke easier to inhale [33]. Further-
more, the potential for addiction is increased through its
desensitization ability to nicotine, longer exposure and tol-
erance to nicotine. Finally the risk of cancer is increased
by absorption of tobacco smoke components into the lung
[33-36]. Menthol can be contained in several parts of ciga-
rettes, such as in the filter, paper and also in flavored
liquids.
Recent studies confirm that the addition of menthol
leads to a number of negative effects [37,38]. Furthermore,
it was shown that menthol increases the flux of the
tobacco-related compounds nitrosamine and nitrosonor-
nicotine across porcine esophagus [39]. It is remarkable
that one third of diagnosed esophageal cancers in 1998
was found in females [40] and that about a third of female
smokers preferred menthol cigarettes [41].
The harmful effect of additives, in particular with menthol
flavor could also be observed and confirmed in our study.
Results from numerous studies providing evidence of a
negative influence of menthol additives in cigarettes have
lead in 2013 to the decision to ban menthol containing
cigarettes in the European Community; in addition, it was
proposed to harmonize the regulations of e-cigarettes,
which presently differ between the countries in the EU,
and to restrict their advertising [42]. Since the present
study shows that in particular menthol additives in e-
cigarettes had a harmful effect on human fibroblast cells,
it might be considered to prohibit the use of this additive
not only in conventional cigarettes but also in e-cigarettes.
Within its limits, the present in vitro study demon-
strated that menthol additives of e-smoking have a harm-
ful effect on human periodontal ligament fibroblasts. This
might indicate that it is preferable for e-cigarettes not to
contain menthol additives.Competing interests
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